Partnership Updates

Myeloid Cure and MSD Launch Clinical Co-Development of Antibody Therapies in Autoimmune Diseases

On May 12, 2026, Myeloid Cure is hnonored to announce the signing of a joint development cooperation agreement with the MSD R&D China Innovation Collaboration Center. The two parties will collaborate on the clinical co-development of antibody therapeutics in the autoimmune disease space.

Partnership Updates

Myeloid Cure Invited to Inaugural MSD R&D China Science Day, Signs Letter of Intent with MSD R&D China

Beijing, China, November 11, 2025 — Today, MSD China R&D Center successfully hosted the inaugural MSD R&D China Science Day in Beijing. The event brought together guests from research institutes, medical institutions, biotech enterprises and the financial sector to explore